[Federal Register Volume 64, Number 101 (Wednesday, May 26, 1999)]
[Notices]
[Page 28501]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13348]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Ear, Nose, and Throat Devices Panel of the Medical Devices 
Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

     This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Ear, Nose, and Throat Devices Panel of the 
Medical Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 18, 1999, 8:30 a.m. 
to 5:30 p.m.
    Location: Corporate Bldg., conference room 020B, 9200 Corporate 
Blvd., Rockville, MD.
    Contact Person: Harry R. Sauberman, Center for Devices and 
Radiological Health (HFZ-460), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-594-2080, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12522. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will discuss generic issues relating to the 
safety and efficacy of middle ear amplification devices.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by June 4, 1999. 
Oral presentations from the public will be scheduled between 
approximately 9 a.m. and 10 a.m., and for an additional 30 minutes near 
the end of the committee deliberations. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before June 4, 1999, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On June 18, 1999, from 4:30 p.m. to 
5:30 p.m., the meeting will be closed to the public to permit 
discussion and review of trade secret and/or confidential commercial 
information (5 U.S.C. 552b(c)(4)) relating to present and future agency 
issues.
     Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: May 20, 1999.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 99-13348 Filed 5-25-99; 8:45 am]
BILLING CODE 4160-01-F